Skip to main content

Table 2 Relationship between TLR2, TLR4 and TLR9 SNPs and the occurrence of HCMV infection among pregnant women

From: Toll-like receptors genes polymorphisms and the occurrence of HCMV infection among pregnant women

Gene polymorphism

Genetic model

Genotype

Genotype prevalence rates; n (%) a

ORb (95% CI) c

P-valued

Infected cases

Uninfected controls

TLR2 2258 G > A

-

GG

62 (93.9%)

59 (92.2%)

1.00

 

GA

4 (6.1%)

5 (7.8%)

0.76 (0.19–2.97)

0.690

TLR4 896 A > G

-

AA

56 (91.8%)

53 (86.9%)

1.00

 

AG

5 (8.2%)

8 (13.1%)

0.59 (0.18–1.92)

0.380

TLR4 1196 C > T

-

CC

60 (90.9%)

55 (87.3%)

1.00

 

CT

6 (9.1%)

8 (12.7%)

0.69 (0.22–2.11)

0.510

TLR9 2848 G > A

Codominant

GG

8 (13.3%)

13 (20.3%)

0.39 (0.13–1.13)

0.093

GA

25 (41.7%)

34 (53.1%)

0.46 (0.21–1.03)

AA

27 (45.0%)

17 (26.6%)

1.00

Dominant

AA

27 (45.0%)

17 (26.6%)

1.00

 

GA-GG

33 (55.0%)

47 (73.4%)

0.44 (0.21–0.94)

0.032

Recessive

AA-GA

52 (86.7%)

51 (79.7%)

1.00

 

GG

8 (13.3%)

13 (20.3%)

0.60 (0.23–1.58)

0.300

Overdominant

GG-AA

35 (58.3%)

30 (46.9%)

1.00

 

GA

25 (41.7%)

34 (53.1%)

0.63 (0.31–1.28)

0.200

  1. a n, number of tested pregnant women
  2. b OR, odds ratio
  3. c 95% CI, confidence interval
  4. d logistic regression model; P ≤ 0.050 is considered as significant